CORC

浏览/检索结果: 共150条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Sunitinib Malate 期刊论文
出版物, 3111, 卷号: 37, 期号: 0, 页码: 363-388
作者:  Mohammed Gabr Kassem;  A.F.M.Motiur Rahman;  Hesham M.Korashy
收藏  |  浏览/下载:69/0  |  提交时间:2017/07/21
PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma 期刊论文
THERANOSTICS, 2021, 卷号: 11, 期号: 11, 页码: 5387-5403
作者:  Wang, Jianfeng;  Wang, Chen;  Xu, Pan;  Li, Xiao;  Lu, Yongning
收藏  |  浏览/下载:127/0  |  提交时间:2021/05/24
Development of Taccalonolide AJ-Hydroxypropyl-beta-Cyclodextrin Inclusion Complexes for Treatment of Clear Cell Renal-Cell Carcinoma 期刊论文
MOLECULES, 2020, 卷号: 25, 期号: 23, 页码: 14
作者:  Han, Jing;  Zhang, Siwang;  Niu, Junxin;  Zhang, Chunli;  Dai, Weichen
收藏  |  浏览/下载:26/0  |  提交时间:2021/05/24
Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent 期刊论文
ACTA PHARMACEUTICA SINICA B, 2020, 卷号: 10
作者:  Jiang, Zongru;  Wang, Li;  Liu, Xuesong;  Chen, Cheng;  Wang, Beilei
收藏  |  浏览/下载:23/0  |  提交时间:2020/11/26
Impaired clearance of sunitinib leads to metabolic disorders and hepatotoxicity 期刊论文
BRITISH JOURNAL OF PHARMACOLOGY, 2019, 卷号: 176, 期号: 13, 页码: 2162-2178
作者:  Zhao, Qi;  Zhang, Ting;  Xiao, Xue-Rong;  Huang, Jian-Feng;  Wang, Yan
收藏  |  浏览/下载:55/0  |  提交时间:2019/07/29
Exploring binding mechanisms of VEGFR2 with three drugs lenvatinib, sorafenib, and sunitinib by molecular dynamics simulation and free energy calculation 期刊论文
CHEMICAL BIOLOGY & DRUG DESIGN, 2019, 卷号: 93, 期号: 5, 页码: 934-948
作者:  Wang, Yu;  Peng, Cheng;  Wang, Guimin;  Xu, Zhijian;  Luo, Yongfeng
收藏  |  浏览/下载:16/0  |  提交时间:2020/07/01
Impaired clearance of sunitinib leads to metabolic disorders and hepatotoxicity 期刊论文
BRITISH JOURNAL OF PHARMACOLOGY, 2019, 卷号: 176, 期号: 13
作者:  Zhao, Qi;  Zhang, Ting;  Xiao, Xue-Rong;  Huang, Jian-Feng;  Wang, Yan
收藏  |  浏览/下载:25/0  |  提交时间:2019/12/04
Cytoreductive surgery for metastatic gastrointestinal stromal tumors followed by sunitinib compared to followed by imatinib-a multi-center cohort study 期刊论文
EJSO, 2019, 卷号: 45, 期号: 3
作者:  Zhang, Xinhua;  Zhou, Ye;  Wu, Xin;  Nie, Mingming;  Zhang, Bo
收藏  |  浏览/下载:26/0  |  提交时间:2019/12/05
Overexpression of miR-15b Promotes Resistance to Sunitinib in Renal Cell Carcinoma 期刊论文
JOURNAL OF CANCER, 2019, 卷号: 10, 期号: 15
作者:  Lu, Lu;  Li, Yanmin;  Wen, Hui;  Feng, Chenchen
收藏  |  浏览/下载:13/0  |  提交时间:2019/12/05
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial 期刊论文
ONCOLOGIST, 2019, 卷号: 24, 期号: 8
作者:  Zhou, Ai-Ping;  Bai, Yuxian;  Song, Yan;  Luo, Hong;  Ren, Xiu-Bao
收藏  |  浏览/下载:30/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace